Condition: Cancer · Depression · Sponsor: Dartmouth-Hitchcock Medical Center
The purpose of this study is to determine the extent to which an online pathway to depression treatment (iPath\*D) is acceptable and usable to patients receiving cancer treatment who report symptoms of depression.
This description comes directly from the study's public registry record.
Susan Tarczewski · 603-646-7066 · susan.m.tarczewski@dartmouth.edu
Paul Barr, Ph.D. · 603-646-7016 · paul.j.barr@dartmouth.edu
Always discuss trial participation with your own doctor first.
| Dartmouth Cancer Center St. Johnsbury | Saint Johnsbury, Vermont, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05302375